Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 80 mg vs 160 mg aspirin for prevention of preeclampsia in women with abnormal uterine artery Doppler
IRCT20210804052071N1Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin in preeclampsia (2 arms), sponsored by Sabzevar University of Medical Sciences. Started Jan 2022; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20210804052071N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210804052071N1.